CJC-1295 No DAC is a lyophilized, research-use-only peptide belonging to the growth hormone releasing hormone (GHRH) analog family. Unlike the original CJC-1295, this version excludes the Drug Affinity Complex (DAC), which gives it a shorter half-life and makes it a common reference compound in receptor-binding and short-duration in vitro studies. Researchers sometimes refer to it by its other common name, Mod GRF 1-29. Helix Bio supplies this peptide strictly for laboratory and research applications — it is not intended, labeled, or sold for human use.
HPLC certified
Independent analysis
Highest standard
Full traceability
CJC-1295 No DAC is a synthetic 29-amino-acid peptide fragment modeled on the structure of human growth hormone releasing hormone (GHRH). It's frequently used in laboratory settings to study GHRH receptor activity, growth hormone secretion pathways, and peptide stability, without the extended circulating half-life that the DAC-modified version introduces. Because the DAC group is absent, the compound clears more quickly in in vitro and animal-model systems, which many researchers find useful when a shorter, more controllable experimental window is needed.
The product is a lyophilized (freeze-dried) powder consisting of the CJC-1295 No DAC peptide sequence. Lyophilization is used industry-wide to preserve peptide integrity during storage and transit, since peptides in solution degrade far faster than they do in powder form.
This product is manufactured and sold exclusively for in vitro laboratory research, analytical testing, and other non-clinical scientific applications. It is not a drug, dietary supplement, or cosmetic, and it is not approved by the FDA for diagnostic, therapeutic, or any other human or veterinary use.
Researchers working on GHRH receptor studies often need a peptide with predictable, well-documented clearance behavior. CJC-1295 No DAC gives you that reference point without the extended activity window that the DAC-modified analog introduces, which is useful when your protocol calls for a shorter observation period or when you're comparing results against Mod GRF 1-29 literature. Helix Bio sources and packages this peptide specifically for the research community, with documentation practices designed to support reproducible laboratory work rather than retail or personal use.
This product is not intended for individual consumers, and Helix Bio does not sell it for personal, medical, or performance use.
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Cyclic peptides resist protease degradation and reach undruggable targets. Learn how peptide cyclization works and why stability improves. Explore the research.
How continuous flow, automation, enzymatic routes and AI are changing peptide synthesis technology, and what it means for research peptide purity and supply.
AI now designs peptides from scratch. How AlphaFold 3, RFdiffusion and protein language models reshaped peptide discovery in 2026 — research use only.
